
Barclays
BCLYF | OTC
$6.46
+$0.03 (+0.47%)
At close: Sep 21, 2026, 3:31 PM ET
$6.46
$0 (0.00%)
After-hours:
Sep 21, 2026, 4:00 PM ET
Fiscal Year Period Ending | FY 2024 Dec 30, 2024 | FY 2023 Dec 30, 2023 | FY 2022 Dec 30, 2022 | FY 2021 Dec 30, 2021 | FY 2020 Dec 30, 2020 | FY 2019 Dec 30, 2019 |
|---|---|---|---|---|---|---|
Revenue | 24.25B | 23.5B | 23.74B | 22.59B | 16.95B | 21.63B |
Cost of Revenue | 25.39B | 22.37B | 8.52B | 3.17B | n/a | n/a |
Gross Profit | 26.23B | 23.5B | 24.96B | 22.59B | 16.95B | 21.63B |
Operating Income | 8.32B | 7.6B | 8.84B | 9.03B | 3.51B | 6.31B |
Interest Income | 38.33B | 35.08B | 19.1B | 11.24B | 11.89B | 15.46B |
Pretax Income | 8.11B | 6.56B | 7.01B | 8.19B | 3.07B | 4.36B |
Net Income | 6.31B | 5.26B | 5.93B | 7.01B | 2.38B | 3.27B |
Selling & General & Admin | 2.77B | 2.6B | 2.27B | 1.97B | 2.01B | 2.07B |
Research & Development | n/a | n/a | n/a | n/a | n/a | n/a |
Other Expenses | 15.35B | 16.23B | 12.63B | 11.79B | 11.42B | 11.38B |
Operating Expenses | 18.12B | 18.83B | 14.9B | 13.76B | 13.44B | 13.45B |
Interest Expense | 25.39B | 22.37B | 8.52B | 3.17B | 3.77B | 6.05B |
Selling & Marketing Expenses | 649M | 585M | 500M | 399M | 330M | 425M |
Cost & Expenses | 15.96B | 15.9B | 14.9B | 13.56B | 13.44B | 13.45B |
Income Tax Expense | 1.75B | 1.23B | 1.04B | 1.14B | 604M | 1B |
Shares Outstanding (Basic) | 14.76B | 15.45B | 16.33B | 16.99B | 17.3B | 17.2B |
Shares Outstanding (Diluted) | 15.27B | 15.9B | 16.87B | 17.42B | 17.67B | 17.48B |
EPS (Basic) | 0.36 | 0.28 | 0.31 | 0.37 | 0.09 | 0.14 |
EPS (Diluted) | 0.35 | 0.27 | 0.30 | 0.36 | 0.09 | 0.14 |
EBITDA | 9.81B | 8.34B | 8.74B | 9.87B | n/a | n/a |
EBIT | 8.11B | 6.56B | 7.01B | 8.19B | -1.73B | -1.52B |
Depreciation & Amortization | 1.7B | 1.78B | 1.72B | 1.67B | 1.54B | 1.49B |
Add to Watchlist
Select watchlists to add or remove BCLYF